Elon Musk’s brain-computer interface startup, Neuralink, got FDA permission for its first human clinical trial. This milestone advances the company’s objective of brain-computer connection. Neuralink’s implants attempt to integrate the brain with technology.
Neuralink tweeted its joy with the FDA’s clearance and thanked the FDA for its collaboration. This milestone for Neuralink’s technology comes before clinical trial recruitment.
Musk stressed the Neuralink implants’ goal of direct brain-computer interface at a December presentation. Before starting human studies, the business has been rigorously ensuring gadget safety and efficacy.
The presentation showed animals implanted with Neuralink’s coin-sized prototypes. Neuralink implants allowed these animals to play simple video games and operate cursors. Musk envisions the technology expanding beyond games and restoring eyesight and movement to the disabled.
Musk’s ambitions go beyond medicine. He hopes Neuralink will help humans stay up with artificial intelligence. He believes a direct brain-computer interface can restore complete bodily functions to spinal cord-injured people.
Musk’s track record and bold forecasts have garnered interest for Neuralink, which competes with Synchron, which implanted the first US brain-machine interface. The clinical study’s outcomes will be constantly monitored to determine Neuralink’s potential influence on human life and human-computer interaction.
